Compare CMCO & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMCO | XOMA |
|---|---|---|
| Founded | 1875 | 1981 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.4M | 471.6M |
| IPO Year | 2002 | N/A |
| Metric | CMCO | XOMA |
|---|---|---|
| Price | $14.81 | $41.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $21.00 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 667.4K | 91.2K |
| Earning Date | 05-27-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $936,240,000.00 | N/A |
| Revenue This Year | $19.73 | $24.59 |
| Revenue Next Year | $82.91 | N/A |
| P/E Ratio | ★ N/A | $29.64 |
| Revenue Growth | ★ 3.27 | N/A |
| 52 Week Low | $11.99 | $22.29 |
| 52 Week High | $24.40 | $42.81 |
| Indicator | CMCO | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 59.80 |
| Support Level | $14.03 | $37.00 |
| Resistance Level | $16.16 | $42.25 |
| Average True Range (ATR) | 0.99 | 0.36 |
| MACD | 0.08 | -0.16 |
| Stochastic Oscillator | 68.35 | 48.48 |
Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.